164 related articles for article (PubMed ID: 17032905)
1. Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes.
Dipace C; Sung U; Binda F; Blakely RD; Galli A
Mol Pharmacol; 2007 Jan; 71(1):230-9. PubMed ID: 17032905
[TBL] [Abstract][Full Text] [Related]
2. The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current.
Binda F; Lute BJ; Dipace C; Blakely RD; Galli A
Neuropharmacology; 2006 Mar; 50(3):354-61. PubMed ID: 16289633
[TBL] [Abstract][Full Text] [Related]
3. Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins.
Apparsundaram S; Schroeter S; Giovanetti E; Blakely RD
J Pharmacol Exp Ther; 1998 Nov; 287(2):744-51. PubMed ID: 9808705
[TBL] [Abstract][Full Text] [Related]
4. Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.
Binda F; Dipace C; Bowton E; Robertson SD; Lute BJ; Fog JU; Zhang M; Sen N; Colbran RJ; Gnegy ME; Gether U; Javitch JA; Erreger K; Galli A
Mol Pharmacol; 2008 Oct; 74(4):1101-8. PubMed ID: 18617632
[TBL] [Abstract][Full Text] [Related]
5. Involvement of threonine 258 and serine 259 motif in amphetamine-induced norepinephrine transporter endocytosis.
Annamalai B; Mannangatti P; Arapulisamy O; Ramamoorthy S; Jayanthi LD
J Neurochem; 2010 Oct; 115(1):23-35. PubMed ID: 20626559
[TBL] [Abstract][Full Text] [Related]
6. Calcium-dependent interactions of the human norepinephrine transporter with syntaxin 1A.
Sung U; Blakely RD
Mol Cell Neurosci; 2007 Feb; 34(2):251-60. PubMed ID: 17188889
[TBL] [Abstract][Full Text] [Related]
7. Repeated amphetamine couples norepinephrine transporter and calcium channel activities in PC12 cells.
Kantor L; Zhang M; Guptaroy B; Park YH; Gnegy ME
J Pharmacol Exp Ther; 2004 Dec; 311(3):1044-51. PubMed ID: 15340003
[TBL] [Abstract][Full Text] [Related]
8. Modulation of amphetamine-stimulated [3H]dopamine release from rat pheochromocytoma (PC12) cells by sigma type 2 receptors.
Weatherspoon JK; Werling LL
J Pharmacol Exp Ther; 1999 Apr; 289(1):278-84. PubMed ID: 10087015
[TBL] [Abstract][Full Text] [Related]
9. Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition.
Melikian HE; Ramamoorthy S; Tate CG; Blakely RD
Mol Pharmacol; 1996 Aug; 50(2):266-76. PubMed ID: 8700133
[TBL] [Abstract][Full Text] [Related]
10. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.
Johnson LA; Furman CA; Zhang M; Guptaroy B; Gnegy ME
Neuropharmacology; 2005 Nov; 49(6):750-8. PubMed ID: 16212991
[TBL] [Abstract][Full Text] [Related]
11. Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism.
Wei Y; Williams JM; Dipace C; Sung U; Javitch JA; Galli A; Saunders C
Mol Pharmacol; 2007 Mar; 71(3):835-42. PubMed ID: 17164407
[TBL] [Abstract][Full Text] [Related]
12. Roles of hippocampal N-methyl-D-aspartate receptors and calcium/calmodulin-dependent protein kinase II in amphetamine-produced conditioned place preference in rats.
Sakurai S; Yu L; Tan SE
Behav Pharmacol; 2007 Sep; 18(5-6):497-506. PubMed ID: 17762518
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C and intracellular calcium are required for amphetamine-mediated dopamine release via the norepinephrine transporter in undifferentiated PC12 cells.
Kantor L; Hewlett GH; Park YH; Richardson-Burns SM; Mellon MJ; Gnegy ME
J Pharmacol Exp Ther; 2001 Jun; 297(3):1016-24. PubMed ID: 11356924
[TBL] [Abstract][Full Text] [Related]
14. Functional importance of the C-terminus of the human norepinephrine transporter.
Distelmaier F; Wiedemann P; Brüss M; Bönisch H
J Neurochem; 2004 Nov; 91(3):537-46. PubMed ID: 15485485
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the human norepinephrine transporter by cocaine and amphetamine.
Zhu MY; Shamburger S; Li J; Ordway GA
J Pharmacol Exp Ther; 2000 Dec; 295(3):951-9. PubMed ID: 11082428
[TBL] [Abstract][Full Text] [Related]
16. MHC Class II levels and intracellular localization in human dendritic cells are regulated by calmodulin kinase II.
Herrmann TL; Agrawal RS; Connolly SF; McCaffrey RL; Schlomann J; Kusner DJ
J Leukoc Biol; 2007 Sep; 82(3):686-99. PubMed ID: 17586661
[TBL] [Abstract][Full Text] [Related]
17. The human norepinephrine transporter in combination with 11C-m-hydroxyephedrine as a reporter gene/reporter probe for PET of gene therapy.
Buursma AR; Beerens AM; de Vries EF; van Waarde A; Rots MG; Hospers GA; Vaalburg W; Haisma HJ
J Nucl Med; 2005 Dec; 46(12):2068-75. PubMed ID: 16330572
[TBL] [Abstract][Full Text] [Related]
18. Rab11 supports amphetamine-stimulated norepinephrine transporter trafficking.
Matthies HJ; Moore JL; Saunders C; Matthies DS; Lapierre LA; Goldenring JR; Blakely RD; Galli A
J Neurosci; 2010 Jun; 30(23):7863-77. PubMed ID: 20534835
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins.
Sung U; Jennings JL; Link AJ; Blakely RD
Biochem Biophys Res Commun; 2005 Aug; 333(3):671-8. PubMed ID: 15963952
[TBL] [Abstract][Full Text] [Related]
20. A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity.
Sung U; Apparsundaram S; Galli A; Kahlig KM; Savchenko V; Schroeter S; Quick MW; Blakely RD
J Neurosci; 2003 Mar; 23(5):1697-709. PubMed ID: 12629174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
